Myasthenia gravis Trials in Los Angeles, United States
Conditions / Myasthenia gravis / Los Angeles, United States
Research into Myasthenia gravis spans multiple therapeutic approaches and trial phases.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04951622 | A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis | RECRUITING | PHASE3 |
| NCT05150210 | SP Thoracic IDE Study | ACTIVE_NOT_RECRUITING | NA |
| NCT03759366 | A Phase 3 Open-Label Study of Eculizumab in Pediatric Participants With Refractory Generalized Myasthenia Gravis (gMG) | COMPLETED | PHASE3 |
| NCT02110706 | BeatMG: Phase II Trial of Rituximab In Myasthenia Gravis | COMPLETED | PHASE2 |
| NCT02965573 | A Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness | COMPLETED | PHASE2 |
| NCT03052751 | Study to Test the Safety, Tolerability and Efficacy of UCB7665 in Subjects With Moderate to Severe Myasthenia Gravis | COMPLETED | PHASE2 |
| NCT05265273 | A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis | RECRUITING | PHASE2/PHASE3 |
| NCT06002945 | Exploring Outcomes and Characteristics of Myasthenia Gravis 2 | ACTIVE_NOT_RECRUITING | — |
| NCT00294658 | Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy | COMPLETED | PHASE3 |
| NCT06626919 | A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases | RECRUITING | PHASE1 |